Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol in Fabry Disease
NCT02090608Completed
- Sponsor
- University of Naples Federico II
- Start
- Mar 2012
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label, single-arm trial of paricalcitol in Fabry disease (FD), sponsored by University of Naples Federico II. Primary endpoint: Effect of paricalcitol on proteinuria reduction at 6 months. Started Mar 2012; status: completed.
02
Drugs
paricalcitol
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT02090608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02090608.